Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyna Turner

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Psychiatric Research|August 26, 2021
Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trialChiara C Bortolasci, Alyna Turner, Mohammadreza Mohebbi, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
Heart, Lung & Circulation|December 7, 2013
Resumption of work after acute coronary syndrome or coronary artery bypass graft surgeryMarian U Worcester, Peter C Elliott, Alyna Turner, et al.
Addictive Behaviors|July 31, 2020
Insight in substance use disorder: A systematic review of the literatureDayle Raftery, Peter J Kelly, Frank P Deane, et al.
Trials|August 10, 2016
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trialDavid R Skvarc, Olivia M Dean, Linda K Byrne, et al.
BMC Medicine|February 18, 2019
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
BMC Medicine|January 26, 2019
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
Frontiers in Psychiatry|April 4, 2019
"Quitlink"-A Randomized Controlled Trial of Peer Worker Facilitated Quitline Support for Smokers Receiving Mental Health Services: Study ProtocolAmanda L Baker, Ron Borland, Billie Bonevski, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 23, 2020
Adjunctive <i>Garcinia mangostana</i> Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placeboAlyna Turner, Andrea Baker, Olivia M Dean, et al.
BMJ Open|March 22, 2020
Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysisChiara C Bortolasci, Wolfgang Marx, Adam J Walker, et al.
Journal of Psychiatric Research|August 26, 2021
Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trialChiara C Bortolasci, Alyna Turner, Mohammadreza Mohebbi, et al.
Journal of Affective Disorders|November 16, 2020
Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disordersBianca E Kavanagh, Melanie M Ashton, Stephanie P Cowdery, et al.
Heart, Lung & Circulation|December 7, 2013
Resumption of work after acute coronary syndrome or coronary artery bypass graft surgeryMarian U Worcester, Peter C Elliott, Alyna Turner, et al.
Addictive Behaviors|July 31, 2020
Insight in substance use disorder: A systematic review of the literatureDayle Raftery, Peter J Kelly, Frank P Deane, et al.
Trials|August 10, 2016
The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trialDavid R Skvarc, Olivia M Dean, Linda K Byrne, et al.
BMC Medicine|February 18, 2019
Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
BMC Medicine|January 26, 2019
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placeboMichael Berk, Alyna Turner, Gin S Malhi, et al.
Frontiers in Psychiatry|April 4, 2019
"Quitlink"-A Randomized Controlled Trial of Peer Worker Facilitated Quitline Support for Smokers Receiving Mental Health Services: Study ProtocolAmanda L Baker, Ron Borland, Billie Bonevski, et al.
Pageof 12